Chronic Wound Care Market Growth Drivers and Challenges:
Growth Drivers
- Global Upsurge in Diabetes Among People - Diabetes mellitus, also known as diabetes, is a metabolic condition that initiates high blood sugar levels. If untreated, diabetes-related high blood sugar damages nerves, eyes, kidneys, and other organs. Diabetes is becoming more prevalent worldwide, resulting in open wounds that do not heal completely. Hence, it is expected to drive the growth of the global chronic wound care market in the upcoming years. According to the World Health Organization (WHO), there are 422 million diabetics worldwide, and diabetes is the leading cause of 1.5 million annual deaths.
- Increase in Burn Injuries – There are wounds that generally take more than 6 weeks and are slow to recover that are termed is chronic burn injuries. Furthermore, intensive care is provided through the use of chronic wound care products, and it is expected to rise the growth of the global chronic wound care market. According to the World Health Organization, nearly 11 million burn injuries occur every year around the globe. Moreover, approximately 180 000 people die as a result of burns annually, worldwide.
- Escalating Ratio of Pressure Ulcers – There has been an increasing incidence of ulcers that is raising the need for therapies in order to treat these wounds. Hence, it is projected to surge the market’s growth over the forecast period. For instance, the worldwide incidence of pressure ulcers has reached nearly 13%, with 9% occurrence of hospital-acquired pressure injury (HAPI).
- Spike in Venous Leg Ulcers - It is estimated that venous leg ulcers affect nearly 1 to 5% of the elderly population in the United States and Europe.
- Surging number of sport injuries- Chronic injuries generally develop with time and usually happen from overuse of one specific area of the body. Therefore, it is anticipated to rise the growth of the global chronic wound care market. In the United States, more than 3 million sports injuries occur each year.
- Advancement in Dressing Material to Treat Chronic Wounds – It was observed in research that, in managing outpatients with diabetic foot ulcers, silver-releasing foam dressings were found to be more successful than silver-containing cream, especially in the beginning stages of wound therapy. Moreover, it has been discovered that a thiolated biodegradable bandage loaded with ZnO nanoparticles improves tissue regeneration and speeds healing.
Challenges
- High Cost of Treatment of Chronic Wound – Chronic wounds require utmost attention for treatment with the help of high-quality products. Furthermore, the cost of these products is high such as wound care devices, advanced wound dressings, and others that makes its difficult for every class of people to opt for them for treatment. Therefore, it is expected to pose as a challenge to the market growth.
- Inadequate Compensation Policies in Emerging Nations
- Rising Concern Among Patients for Urgent Treatments
Chronic Wound Care Market Size and Forecast:
|
Base Year |
2025 |
|
Forecast Period |
2026-2035 |
|
CAGR |
5.2% |
|
Base Year Market Size (2025) |
USD 15.73 billion |
|
Forecast Year Market Size (2035) |
USD 26.11 billion |
|
Regional Scope |
|
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2026, the industry size of chronic wound care is assessed at USD 16.47 billion.
The global chronic wound care market size was valued at around USD 15.73 billion in 2025 and is projected to grow at a CAGR of more than 5.2%, reaching USD 26.11 billion revenue by 2035.
The North America chronic wound care market will hold over 38.1% share by 2035, attributed to a large chronic wound patient pool, high prevalence of diabetic foot ulcers, and supportive reimbursement policies.
Key players in the market include Smith & Nephew PLC, Ölnlycke Health Care AB, ConvaTec, Inc., Integra LifeSciences Corporation, Coloplast A/S, Cardinal Health, Inc., Tissue Regenix Ltd, B. Braun Melsungen AG, MIMEDX, Inc., 3M.